Data / Form D filings / Illumigyn Ltd.
Illumigyn Ltd.: Form D filing
Illumigyn Ltd., a biotechnology company in Neve Ilan, Israel, filed a Form D with the SEC in 2016. The latest, on November 21, 2016, reports $2 million sold of a $5 million offering to 36 investors.
Find out what Illumigyn Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- COMMUNICATION CENTER, Neve Ilan, Israel, 90850
- Phone
- 972-2-570-0170
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1688772
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2016 | New notice | $5,000,000 | $2,000,446 | $2,999,554 | 36 | Nov 9, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Morry Blumenfeld | Director | |
| Jacob Bortman | Director | |
| Richard Stone | Director | |
| Gadi Ganon | Executive Officer | |
| Lior Greenstein | Executive Officer, Director | |
| Moshe Moalem | Director | |
| Ariel Katz | Executive Officer |
Every Form D from the week of Nov 21, 2016 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Illumigyn Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.